stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Protagonist Therapeutics IncPTGX
$140.240.62%0.87
Dopo l'orario di chiusura: 140.240.00 0.00%

Protagonist Therapeutics Inc (PTGX)

Date: 2026-11-03 16:00O: 140.73H: 144.27L: 139.91C: 140.24Vol: 673.5k
Precedente Chiudi:
$139.37
Aprire:
$140.73
Volume 24 ore:
673,520
Volume relativo:
1.18
Capitalizzazione di mercato:
$9.07B
Reddito:
$74.06M
Utile/perdita netta:
-$114.71M
Rapporto P/E:
-
EPS:
-$1.80
Flusso di cassa netto:
-$117.90M
1W Prestazione:
-0.62%
1M Prestazione:
+0.13%
6M Prestazione:
+42.56%
1Y Prestazione:
+84.65%
Intervallo 1D:
$139.91$144.27
Intervallo di 1 settimana:
$138.29$146.44
Portata 52W:
$75.44$160.81

Profilo aziendale di Protagonist Therapeutics Inc (PTGX)

Nome
Protagonist Therapeutics Inc
Settore
Healthcare
Industria
Biotechnology
Telefono
(510) 474-0170
Indirizzo
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, USA
Dipendente
132
X
-
Prossima data di guadagno
2026-11-05
Ultimi documenti SEC
SEC
Discussioni di PTGX su X
X

 

Cap. di mercato

 

Reddito

 

Reddito netto

 

Flusso di cassa

 

EPS

 

Protagonist Therapeutics Inc Azioni (PTGX) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-10-12IniziatoUBSBuy
2026-08-10AggiornamentoGoldmanNeutral → Buy
2026-05-21IniziatoWolfe ResearchOutperform
2025-09-17IniziatoBarclaysOverweight

Protagonist Therapeutics Inc Azioni (PTGX) Dati Finanziari

PeriodoAndamentoFY 2025FY 2024FY 2023FY 2022FY 2021
Data di fine periodo2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)46.02434.4360.0026.5827.36
Research and development USD (M)159.29138.13120.16126.22126.01
Operating expenses USD (M)204.14181.59153.65157.95153.20
Operating income USD (M)-158.13252.84-93.65-131.37-125.85
Income before tax USD (M)-129.31279.41-78.96-127.39-125.55
Income tax expense USD (M)0.844.220.000.000.00
Net income USD (M)-130.15275.19-78.96-127.39-125.55
Basic EPS USD/shares-2.054.47-1.39-2.60-
Diluted EPS USD/shares-2.054.23-1.39-2.60-
Basic weighted shares shares (M)63.5761.5756.7649.04-
Diluted weighted shares shares (M)63.5765.0856.7649.04-

Protagonist Therapeutics Inc Azioni (PTGX) insider trading

  • Ali AsifSep 30 '26
    Chief Financial Officer
    Transazione
    Option Exercise
    Costo
    $23.72
    #Azioni
    58,629
    Valore ($)
    1,390,735
    #Azioni Totale
    117,632
  • Ali AsifSep 30 '26
    Chief Financial Officer
    Transazione
    Sale
    Costo
    $141.78
    #Azioni
    58,629
    Valore ($)
    8,312,294
    #Azioni Totale
    59,003
  • ASIF ALISep 30 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $140.97
    #Azioni
    58,629
    Valore ($)
    8,264,930
    #Azioni Totale
    0
  • President and CEO
    Transazione
    Sale
    Costo
    $144.10
    #Azioni
    7,278
    Valore ($)
    1,048,760
    #Azioni Totale
    522,968
  • President and CEO
    Transazione
    Option Exercise
    Costo
    $21.58
    #Azioni
    7,278
    Valore ($)
    157,059
    #Azioni Totale
    530,246
  • President and CEO
    Transazione
    Option Exercise
    Costo
    $21.58
    #Azioni
    63,548
    Valore ($)
    1,371,366
    #Azioni Totale
    586,516
  • President and CEO
    Transazione
    Sale
    Costo
    $146.18
    #Azioni
    63,548
    Valore ($)
    9,289,447
    #Azioni Totale
    522,968
  • President and CEO
    Transazione
    Sale
    Costo
    $145.87
    #Azioni
    54,174
    Valore ($)
    7,902,361
    #Azioni Totale
    522,968
  • President and CEO
    Transazione
    Option Exercise
    Costo
    $21.58
    #Azioni
    54,174
    Valore ($)
    1,169,075
    #Azioni Totale
    577,142
  • President and CEO
    Transazione
    Sale
    Costo
    $148.52
    #Azioni
    34,239
    Valore ($)
    5,085,176
    #Azioni Totale
    523,478
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Ali AsifChief Financial OfficerSep 30 '26Option Exercise$23.7258,6291,390,735117,632
Ali AsifChief Financial OfficerSep 30 '26Sale$141.7858,6298,312,29459,003
ASIF ALIOfficerSep 30 '26Proposed Sale$140.9758,6298,264,9300
PATEL DINESH V PH DPresident and CEOSep 10 '26Sale$144.107,2781,048,760522,968
PATEL DINESH V PH DPresident and CEOSep 10 '26Option Exercise$21.587,278157,059530,246
PATEL DINESH V PH DPresident and CEOSep 09 '26Option Exercise$21.5863,5481,371,366586,516
PATEL DINESH V PH DPresident and CEOSep 09 '26Sale$146.1863,5489,289,447522,968
PATEL DINESH V PH DPresident and CEOSep 08 '26Sale$145.8754,1747,902,361522,968
PATEL DINESH V PH DPresident and CEOSep 08 '26Option Exercise$21.5854,1741,169,075577,142
PATEL DINESH V PH DPresident and CEOAug 11 '26Sale$148.5234,2395,085,176523,478

Protagonist Therapeutics Inc Borsa (PTGX) Ultime notizie

Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 26, 2026
Oct 26, 2026
Oct 24, 2026
Oct 24, 2026
Oct 24, 2026
Oct 24, 2026
Oct 23, 2026
Oct 23, 2026
Oct 21, 2026
Oct 21, 2026
Oct 20, 2026
Oct 20, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 17, 2026
Oct 17, 2026
Oct 17, 2026
Oct 17, 2026
Oct 17, 2026
Oct 17, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 14, 2026
Oct 14, 2026
Oct 14, 2026
Oct 14, 2026
Oct 14, 2026
Oct 14, 2026
Oct 13, 2026
Oct 13, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 10, 2026
Oct 10, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 07, 2026
Oct 07, 2026
Oct 05, 2026
Oct 05, 2026
Oct 04, 2026
Oct 04, 2026
Oct 03, 2026
Oct 03, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026

Simile a PTGX